Evidence map›Paper›PMID 34276197›Full record

ArticleAnnals of gastroenterology

Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Karn Wijarnpreecha, Elizabeth S Aby, Panadeekarn Panjawatanan, Kamolyut Lapumnuaypol, Wisit Cheungpasitporn, Frank J Lukens, Denise M Harnois, Patompong Ungprasert

Open access · diamondAbstract read
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Karn WijarnpreechaDivision of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA (Karn Wijarnpreecha, Denise M. Harnois).
Elizabeth S AbyDepartment of Medicine, University of California at Los Angeles, CA, USA (Elizabeth S. Aby, Frank J. Lukens).
Panadeekarn PanjawatananDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand (Panadeekarn Panjawatanan).
Kamolyut LapumnuaypolDepartment of Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA (Kamolyut Lapumnuaypol).
Wisit CheungpasitpornDepartment of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, USA (Wisit Cheungpasitporn).
Frank J LukensDepartment of Medicine, University of California at Los Angeles, CA, USA (Elizabeth S. Aby, Frank J. Lukens).
Denise M HarnoisDivision of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA (Karn Wijarnpreecha, Denise M. Harnois).
Patompong UngprasertClinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand (Patompong Ungprasert).
Mayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have suggested an association between modest alcohol consumption and a decreased risk of advanced liver fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) although the results are inconsistent. The current systematic review and meta-analysis was conducted to comprehensively investigate this possible association by identifying all the relevant studies and combining their results.

methodsA comprehensive literature review was conducted utilizing the MEDLINE and EMBASE databases through February 2019 to identify all cross-sectional studies that compared the prevalence of advanced liver fibrosis among NAFLD patients who were modest alcohol drinkers to NAFLD patients who were non-drinkers. Effect estimates from each study were extracted and combined together using the random-effect, generic inverse variance method of DerSimonian and Laird.

resultsA total of 6 studies with 8,936 participants fulfilled the eligibility criteria and were included in the meta-analysis. The risk of advanced liver fibrosis among patients with NAFLD who were modest alcohol drinkers was significantly lower compared to patients with NAFLD who were non-drinkers with a pooled odds ratio of 0.51 (95% confidence interval [CI] 0.35-0.75; I

conclusionA significantly lower risk of advanced liver fibrosis was observed among NAFLD patients who were modest alcohol drinkers compared to non-drinkers in this meta-analysis.

Indexed as

alcoholHepatic steatosisliver fibrosismeta-analysisnonalcoholic steatohepatitis

Identifiers

PMID34276197
PMCPMC8276361
OpenAlexW3133723755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.